Regulatory
CRN hopeful about future of MPL in upcoming legislative sessions
January 3rd 2023The Council for Responsible Nutrition has issued a statement expressing disappointment at the exclusion of a mandatory product listing provision from the recently passed omnibus spending package. However, the association sees its passage as inevitable.
AHPA requests that Congress not consider MPL during lame duck session in recent letter
December 2nd 2022Given the interest in reviewing and considering amendments to several provisions of FD&C that would affect dietary supplements, AHPA believes strongly that these amendments should be addressed collectively in the 118th Congress. That way, stakeholders can fully engage with Congress.
In conversation with the Natural Products Association at SupplySide West 2022
December 1st 2022Sebastian Krawiec, editor of Nutritional Outlook, talked to Daniel Fabricant, president and CEO of the Natural Products Association about a recent Marist Poll sponsored by the organization, and regulatory priorities.
In conversation with the Council for Responsible Nutrition at SupplySide West 2022
December 1st 2022Sebastian Krawiec, editor of Nutritional Outlook talks to Steve Mister, president and CEO of the Council for Responsible Nutrition about the organization’s recent consumer survey and its regulatory priorities before the close of the legislative session and beyond.
FDA sends warning letters to dietary supplement companies claiming to treat cardiovascular disease
November 18th 2022On November 17, the agency sent warning letters to Essential Elements, Calroy Health Sciences, Iwi, BergaMet North America, Healthy Trends Worldwide, Chambers’ Apothecary, and Anabolic Laboratories.